Vanquishing the Virus

In this on demand debut of “GEN Live”, Julianna LeMieux and Alex Philippidis discuss the latest medical advances in drug and vaccine development, as well as diagnostic and antibody testing. They go beyond the written word to share news and insights, ranking the frontrunner drug and vaccine candidates aiming to vanquish the virus. Attendees were able to ask questions live or via chat/social media.

Self-Amplifying mRNA Vaccines for Pandemic Rapid Response

In this GEN webinar, sponsored by TriLink Biotechnologies, we will hear about data innovations from seven years of research at Novartis Vaccines on self-amplifying mRNA technology and how this approach could enable the concept of vaccines on demand as a rapid response to a real threat rather that the deployment of strategic stockpiles based on epidemiological predictions of a possible threat.

Cross-Functional Drug Discovery of Novel Non-Natural Entities

In TODAY's webinar, sponsored by Dotmatics, we will highlight key features of an informatics solution that supports research of novel, non-natural drug entities such as bicyclic and stapled peptides, antibody- and peptide-drug conjugates, and non-natural RNAs.

Exploring Novel Vaccine Characterization Methodologies

In this GEN webinar, we will discuss some typical workflows used to characterize the properties of vaccines, looking at properties such as particle size, surface charge, aggregation, and protein secondary structure.

COVID-19: Talking Next-Gen Diagnostics

Listen to the science writing talent from GEN in the second "GEN LIVE" interactive conversation on the latest science and medical news from the frontlines of the COVID-19 pandemic. In Episode 2 GEN editors Julianna LeMieux, Alex Philippidis and Kevin Davies will discuss the latest advances in COVID-19 diagnostics. This episode features Janice Chen, PhD, co-founder of Mammoth Biosciences and Jonathan Rothberg, PhD, CSO of 4Catalyzer.

Association Rate Constant: The Unsung Hero of Drug Discovery Kinetics

VIEW NOW Broadcast Date: May 21, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET While the importance of ligand-receptor binding kinetics on drug action is...

Rapid Discovery of Functional Antibodies for SARS-CoV-2 Using the Beacon System

In this GEN webinar, sponsored by Berkeley Lights, we will hear from Anupam Singhal, PhD, who will provide a brief overview of how antibody discovery on the Beacon optofluidic system can be used to screen human B cells for the discovery of antiviral antibodies in under one week. Robert Carnahan, PhD, and Seth Zost, PhD, from the Vanderbilt University Medical Center, will then describe how they have used the Beacon system, to rapidly discover hundreds of unique antibodies against SARS-CoV-2.

The Future of Cellular Immunotherapy: Highly Automated Precision Medicine

In this GEN webinar, learn how Lonza’s Cocoon™ cell therapy manufacturing platform and IsoPlexis’ IsoLight™ single-cell proteomics system can be used together to advance the future of cancer immunotherapy.

Measuring Multivalent Interactions: Uncovering the Secrets of Virus Binding Strategies

VIEW NOW Broadcast Date: June 13, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Influenza A virus (IAV) utilizes a multivalent binding strategy to the...

Recent Advances and the Future of Antibody Engineering

VIEW NOW Broadcast Date: June 11, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET The therapeutic antibody market has reached a fever pitch of enthusiasm,...

Recently Featured

Scroll Up